Role of interleukin-6 (IL-6) in predicting gestational diabetes mellitus

키워드

참고문헌 (46)

1. World Health Organization, "Classification of diabetes mellitus", World Health Organization, ~ (2019)
2. American Diabetes Association, "Classification and diagnosis of diabetes : standards of medical care in diabetes-2019", Diabetes Care, 42, pp.S13~28 (2019)
3. Koivusalo SB, "Gestational diabetes mellitus can be prevented by lifestyle intervention : the Finnish Gestational Diabetes Prevention Study(RADIEL) : a randomized controlled trial", Diabetes Care, 39, pp.24~30 (2016)
4. Sudharshana Murthy KA, "Evaluation of oxidative stress and proinflammatory cytokines in gestational diabetes mellitus and their correlation with pregnancy outcome", Indian J Endocrinol Metab, 22, pp.79~84 (2018)
5. "Diabetes mellitus in pregnancy: screening and diagnosis" (2019)[URL]
6. "Gestational diabetes mellitus: obstetric issues and management" (2019)[URL]
7. Song C, "Lifestyle intervention can reduce the risk of gestational diabetes : a meta-analysis of randomized controlled trials", Obes Rev, 17, pp.960~969 (2016)
8. Mirghani Dirar A, "Gestational diabetes from A to Z", World J Diabetes, 8, pp.489~511 (2017)
9. Cunningham FG, "Williams obstetrics" (2018), Mcgraw-hill
10. World Health Organization, "Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy", World Health Organization, ~ (2013)
11. Amreen S, "Use of glycosylated HbA1c and random blood sugar as a screening tool for gestational diabetes mellitus in first trimester", Int J Reprod Contracept Obstet Gynecol, 7, pp.524~528 (2018)
12. Huhn EA, "Controversies in screening and diagnostic criteria for gestational diabetes in early and late pregnancy", Front Endocrinol(Lausanne), 9, pp.696~ (2018)
13. Siddiqui S, "Augmentation of IL-6 production contributes to development of gestational diabetes mellitus : an Indian study", Diabetes Metab Syndr, 13, pp.895~899 (2019)
14. Suzuki T, "Interleukin-6 enhances glucose-stimulated insulin secretion from pancreatic β-cells : potential involvement of the PLC-IP3-dependent pathway", Diabetes, 60, pp.537~547 (2011)
15. Lainampetch J, "Association of tumor necrosis factor alpha, interleukin 6, and C-reactive protein with the risk of developing type 2 diabetes : a retrospective cohort study of rural thais", J Diabetes Res, 2019, pp.9051929~ (2019)
16. Yang Y, "Functional defects of regulatory T cell through interleukin 10 mediated mechanism in the induction of gestational diabetes mellitus", DNA Cell Biol, 37, pp.278~285 (2018)
17. Braga FO, "Relationship between inflammatory markers, glycated hemoglobin and placental weight on fetal outcomes in women with gestational diabetes", Arch Endocrinol Metab, 63, pp.22~29 (2019)
18. Šimják P, "Changes in plasma concentrations and mRNA expression of hepatokines fetuin A, fetuin B and FGF21 in physiological pregnancy and gestational diabetes mellitus", Physiol Res, 67, pp.S531~42 (2018)
19. Fatemeh Abdi, "A systematic review of the role of vitamin D and calcium in premenstrual syndrome", Obstetrics & Gynecology Science, 62(2), pp.73~86 (2019), 대한산부인과학회
20. Rahnemaie FS, "Effects of complementary medicine on successful breastfeeding and its associated issues in the postpartum period", Iran J Pediatr, 29, pp.e80180~ (2019)
21. Wang X, "Expression and correlation of Chemerin and FABP4 in peripheral blood of gestational diabetes mellitus patients", Exp Ther Med, 19, pp.710~716 (2020)
22. Yu H, "Changes in intestinal flora, TNF-α, L-17, and IL-6 levels in patients with gestational diabetes mellitus", Eur J Inflamm (2018)
23. Zhao X, "Correlation between inflammatory markers(hs-CRP, TNF-α, IL-1β, IL-6, IL-18), glucose intolerance, and gestational diabetes mellitus in pregnant women", Int J Clin Exp Med, 11, pp.8310~8316 (2018)
24. Abell SK, "The association between dysregulated adipocytokines in early pregnancy and development of gestational diabetes", Diabetes Metab Res Rev, 33, pp.e2926~ (2017)
25. Zhang J, "Interleukin 6(IL-6)and tumor necrosis factor α(TNF-α)single nucleotide polymorphisms(SNPs), inflammation and metabolism in gestational diabetes mellitus in Inner Mongolia", Med Sci Monit, 23, pp.4149~4157 (2017)
26. Bossick AS, "Antenatal inflammation and gestational diabetes mellitus risk among pregnant African-American women", J Reprod Immunol, 115, pp.1~5 (2016)
27. Oztop N, "The association of glycemic markers with plasma adipocytokine levels in women with gestational diabetes", J Diabetes Metab, 7, pp.1000699~ (2016)
28. Qu X, "Association of downregulated HDAC 2 with the impaired mitochondrial function and cytokine secretion in the monocytes", macrophages from gestational diabetes mellitus patients, 2016, pp.40, 642~651
29. Gümüş P, "Evaluation of biochemical parameters and local and systemic levels of osteoactive and B-cell stimulatory factors in gestational diabetes in the presence or absence of gingivitis", J Periodontol, 86, pp.387~397 (2015)
30. Hassiakos D, "Increased maternal serum interleukin-6 concentrations at 11 to 14weeks of gestation in low risk pregnancies complicated with gestational diabetes mellitus : development of a prediction model", Horm Metab Res, 48, pp.35~41 (2016)
31. Kim SY, "Total adiponectin, but not inflammatory markers Creactive protein, tumor necrosis factor-α, interluekin-6and monocyte chemoattractant protein-1, correlates with increasing glucose intolerance in pregnant Chinese-Americans", J Diabetes, 6, pp.360~368 (2014)
32. Kuźmicki M, "The IL-6", IL-6R, Endokrynol Pol, pp.2014, 65[DOI]
33. Nergiz S, "Circulating galanin and IL-6 concentrations in gestational diabetes mellitus", Gynecol Endocrinol, 30, pp.236~240 (2014)
34. Özyer Ş, "Inflammation and glycemic tolerance status in pregnancy : the role of maternal adiposity", Gynecol Obstet Invest, 78, pp.53~58 (2014)
35. Mrizak I, "Inflammation and impaired endotheliumdependant vasodilatation in non obese women with gestational diabetes mellitus : preliminary results", Lipids Health Dis, 12, pp.93~ (2013)
36. Abdel Gader AG, "Haemostatic and cytokine changes in gestational diabetes mellitus", Gynecol Endocrinol, 27, pp.356~360 (2011)
37. Morisset AS, "Circulating interleukin-6 concentrations during and after gestational diabetes mellitus", Acta Obstet Gynecol Scand, 90, pp.524~530 (2011)
38. Pöyhönen-Alho M, "Decreased variation of inflammatory markers in gestational diabetes", Diabetes Metab Res Rev, 27, pp.269~276 (2011)
39. Kuzmicki M, "High resistin and interleukin-6 levels are associated with gestational diabetes mellitus", Gynecol Endocrinol, 25, pp.258~263 (2009)
40. Harrison CL, "Risk stratification in early pregnancy for women at increased risk of gestational diabetes", Diabetes Res Clin Pract, 107, pp.61~68 (2015)
41. Farrar D, "Different strategies for diagnosing gestational diabetes to improve maternal and infant health", Cochrane Database Syst Rev, 8, pp.CD007122~ (2017)
42. Weinert LS, "International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy : comment to the International Association of Diabetes and Pregnancy Study Groups consensus panel", Diabetes Care, 33, pp.e97~ (2010)
43. Kleiblova P, "Expression of adipokines and estrogen receptors in adipose tissue and placenta of patients with gestational diabetes mellitus", Mol Cell Endocrinol, 314, pp.150~156 (2010)
44. Khodabandehloo H, "Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction", Transl Res, 167, pp.228~256 (2016)
45. Sun D, "Associations of the prepregnancy BMI and gestational BMI gain with pregnancy outcomes in Chinese women with gestational diabetes mellitus", Int J Clin Exp Med, 7, pp.5784~5789 (2014)
46. Vejrazkova D, "Steroids and insulin resistance in pregnancy", J Steroid Biochem Mol Biol, 139, pp.122~129 (2014)

관련 논문AI추천